4//SEC Filing
Shandell Jason B. 4
Accession 0001104659-19-074973
CIK 0001297184other
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 4:06 PM ET
Size
5.1 KB
Accession
0001104659-19-074973
Insider Transaction Report
Form 4
Shandell Jason B.
DirectorPresident
Transactions
- Sale
Common Stock
2019-12-18$19.13/sh−8,205$156,958→ 138,898 total
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2019.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.06 to $19.39 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Documents
Issuer
Amphastar Pharmaceuticals, Inc.
CIK 0001297184
Entity typeother
Related Parties
1- filerCIK 0001611148
Filing Metadata
- Form type
- 4
- Filed
- Dec 19, 7:00 PM ET
- Accepted
- Dec 20, 4:06 PM ET
- Size
- 5.1 KB